Begg and Co. conquer Goatfell
The date? 6th of April. The challenge? To climb the highest peak on the Isle of Arran. The team? Unstoppable. On a... Read More
NICE: Shared decision making
Author: Susanna Smith; BSc (Hons) Nursing and MSc Public Health Kidney Cancer UK Health Professional I recently had the privilege of attending... Read More
4 year old Nancy smashes the Rookie Run
Nancy ‘Noodle’ Pitt completed her mud run on 19th May and had an incredible time, as you will see by the photos.... Read More
Portugal to Spain – Iain’s journey along the Camino de Santiago
On the 1st of May Iain set out to complete his third camino. Over the next 12 days he would walk 259km... Read More
Cryoablation of Stage T1b RCC Trial Outcome
Percutaneous Cryoablation of Stage T1b Renal Cell Carcinoma: Safety, Technical Results, and Clinical. The use of percutaneous cryoablation for T1b (4.1-7.0 cm)... Read More
Nancy ‘Noodles’ takes on Nuclear Races Rookie Rush
Four -year-old Nancy Kirste Pitt, nick-name ‘Noodles’, is having a huge adventure and joining the Nuclear Races Rookie Rush on Sunday 19th... Read More
C-reactive protein-albumin ratio as a prognostic factor in RCC
C-reactive protein-albumin ratio as a prognostic factor in renal cell carcinoma – A data from multi-institutional study in Japan. The C-reactive protein... Read More
Kidney Cancer Counselling Service
Kidney Cancer UK and Kidney Cancer Scotland provide the UK's first, free, dedicated Kidney Cancer Counselling Service.
How we work with N.I.C.E
How Kidney Cancer UK works with N.I.C.E to bring new drugs treatments to patients Author; Lucy Willingale Bsc (Hons) Oncology and Radiotherapy... Read More
Living With Kidney Cancer days
Check the dates for our nine free to attend, Living With Kidney Cancer days 2019.
It’s okay as a carer to need help
Two years ago, I thought my life was over. Two years, eleven days and a handful of hours ago, a very kind... Read More
NICE recommend nivolumab + ipilimumab combo through CDF
Bristol-Myers Squibb has announced that the National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination (FAD)... Read More
Talking to children about the ‘C’ word: Cancer
By Emma Clark. I want to start, first and foremost, by saying there are no right or wrong answers to this puzzling... Read More
Why immunotherapy is not effective for some patients with metastatic kidney cancer
White blood cells known as B cells have been shown to be effective for predicting which cancer patients will respond to immune... Read More
KiltWalk 2019
We are delighted to be participating in the Kiltwalk fundraising events in Scotland throughout 2019 Glasgow Sunday 28 April Aberdeen Sunday 2nd... Read More
EMA validates Bavencio for review in advanced RCC
The European Medicines Agency (EMA) has validated Merck’s application for Bavencio (avelumab) for the treatment of patients with advanced renal cell carcinoma... Read More
Welding Linked to Kidney Cancer
HSE issues a safety alert for welding fume exposure in kidney and lung cancer This is an alert for anyone who is,... Read More
Survey -Developing a tool to personalise treatment in small kidney tumours
If you are taking this survey on a mobile device, please CLICK HERE. Create your own user feedback survey
European Commission approves nivolumab ipilimumab combo
The European Commission has approved nivolumab in combination with low-dose ipilimumab for first-line treatment of patients with intermediate and poor risk advanced... Read More
Kidney Cancer Awareness Week 4-8 February 2019
Click for more information our national awareness week and join our 'Plant a Seed For Research' campaign.
Walk For A Cure 2019
We are delighted to invite you to take part in Walk For A Cure, although it is focusing on walking in May, you can arrange... Read More
Natalie Newnes: Born to Run
Following a weight loss plan and giving birth to a lovely baby boy, Natalie Newnes started running marathons. Life could not have been... Read More
CHMP adopts a positive opinion of nivolumab + ipilimumab as 1st line treatment
Press release: Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo® (nivolumab) Plus Low-Dose Yervoy® (ipilimumab) as First-Line Treatment for Patients with... Read More
Kidney Cancer patients suffer high levels of stress
Distress Levels High Among Patients With Common Form of Kidney Cancer Many patients with renal cell carcinoma, the most common type of... Read More